Carlo Bernasconi

World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes

Catherine Klersy, R. Zappatore, C. Klersy, 2007, British journal of haematology.

Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.

Ester Orlandi, Alberto Santagostino, A. Livraghi, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.